Hermetica Superfood Encyclopedia
The Short Answer
Vanadium Nicotinate Glycinate Chelate delivers elemental vanadium (1% by weight) complexed with nicotinic acid and glycine, functioning as an insulin mimetic by inhibiting protein tyrosine phosphatases (PTPs) to prolong insulin receptor activation and enhance GLUT4-mediated glucose uptake via the PI3K-Akt pathway. Human studies using various vanadium compounds have demonstrated improvements in insulin sensitivity in type 2 diabetic patients, with oral supplementation elevating serum vanadium to 1–10 μM, though no large-scale randomized controlled trials specific to this chelate form have been completed.
CategoryMineral
GroupMineral
Evidence LevelPreliminary
Primary Keywordvanadium nicotinate glycinate benefits
Vanadium Nicotinate Glycinate — botanical close-up
Health Benefits
**Blood Glucose Regulation**
Vanadium inhibits protein tyrosine phosphatases (PTPs), prolonging insulin receptor tyrosine kinase activation and increasing GLUT4 translocation to cell membranes, thereby enhancing peripheral glucose uptake and lowering circulating blood sugar.
**Insulin Sensitivity Enhancement**
By activating the PI3K-Akt signaling cascade independently of the insulin receptor, vanadium compounds can improve cellular insulin responsiveness even in states of partial insulin resistance, making this chelate form of interest for type 2 diabetes management.
**Gluconeogenesis Inhibition**: Vanadium suppresses the activity of glucose-6-phosphatase and related gluconeogenic enzymes, reducing hepatic glucose output
a key driver of fasting hyperglycemia in type 2 diabetes.
**Improved Bioavailability Over Inorganic Forms**
The nicotinate-glycinate chelation extends vanadium's blood half-life from approximately 5 minutes (for inorganic VOSO₄) to 7–30 minutes in rodent models, facilitating greater organ distribution and more sustained metabolic effects.
**Attenuation of Lipolysis in Adipose Tissue**
Vanadium compounds, including VO(acac)₂, have been shown to reduce glycerol release in adipocytes, indicating suppression of excessive lipolysis that contributes to elevated free fatty acid levels and worsened insulin resistance.
**Mitogenic Signaling Modulation**: At physiological concentrations (2
5–25 μM), vanadium activates ERK and PI3K pathways in a biphasic manner to support normal cellular proliferation, while inhibitory effects predominate above 50 μM, suggesting a concentration-dependent regulatory role in cellular metabolism.
**Reduction of Oxidative Stress Markers (Preclinical)**
Some preclinical evidence suggests vanadium complexes may modulate reactive oxygen species at targeted sites via cysteine oxidation mechanisms, though this remains an area requiring further human investigation.
Origin & History
Natural habitat
Vanadium is a naturally occurring trace mineral found in Earth's crust, present in trace amounts in foods such as mushrooms, shellfish, black pepper, and cereals. It was first isolated in 1801 by Andrés Manuel del Río and later rediscovered by Nils Gabriel Sefström in 1830. The specific chelated form — Vanadium Nicotinate Glycinate — is a modern synthetic preparation developed by companies such as Albion Laboratories and Balchem, in which elemental vanadium is complexed with nicotinate (a niacin derivative) and glycinate (an amino acid) to improve oral bioavailability and reduce toxicity potential.
“Vanadium has no documented use in classical herbal or traditional medicine systems such as Ayurveda, Traditional Chinese Medicine, or indigenous healing traditions, as the element was not isolated until the early 19th century and its biochemical relevance was not recognized until the mid-20th century. Anecdotal interest in vanadium for diabetes management emerged in the 1980s and 1990s following animal studies demonstrating insulin-mimetic effects of vanadate salts, leading to brief popularity of vanadyl sulfate supplements in the bodybuilding community for purported blood sugar and body composition benefits. The Vanadium Nicotinate Glycinate Chelate form itself is a wholly modern pharmaceutical development, engineered for improved tolerability through amino acid and vitamin B3 chelation technology pioneered by Albion Laboratories. There are no indigenous, ethnic, or pre-industrial preparation methods associated with this ingredient.”Traditional Medicine
Scientific Research
The clinical evidence base for Vanadium Nicotinate Glycinate Chelate specifically is absent; no published randomized controlled trials have evaluated this exact form in human subjects. Evidence for vanadium's antidiabetic effects derives from studies using inorganic vanadyl sulfate and organic forms such as bis(maltolato)oxovanadium (BMOV), with small pilot trials in type 2 diabetic patients (typically n=8–16) demonstrating modest improvements in fasting glucose and insulin sensitivity, but without large-scale, long-term efficacy data. Rodent studies consistently show normoglycemic effects with organic vanadium chelates, with improved pharmacokinetics over inorganic salts, but translational relevance to humans requires formal investigation. The overall evidence is preclinical-to-early-clinical, with no dose-response curves, HbA1c endpoints, or cardiovascular outcome data published for the nicotinate-glycinate form, necessitating caution in extrapolating benefits from other vanadium compound research.
Preparation & Dosage
Traditional preparation
**Chelated Powder (1% Elemental Vanadium)**
1 mg elemental vanadium per 100 mg of chelate powder; used as a bulk ingredient in capsules and tablets
The primary commercial form from Albion Labs/Balchem; provides .
**Typical Supplemental Range**
25–100 mcg of elemental vanadium per serving, well below pharmacological doses used in research; no standardized therapeutic dose has been established for this chelate form
Commercial products generally supply .
**Research Doses (Vanadium Compounds Generally)**
100–150 mg/day of vanadyl sulfate (equivalent to ~31–46 mg elemental vanadium/day) for 3–6 weeks — doses significantly higher than most supplement products and not directly applicable to this chelate
Studies using vanadyl sulfate in type 2 diabetes typically administered .
**Timing**
No clinical data exists to guide timing; co-administration with meals may reduce gastrointestinal irritation, consistent with general guidance for mineral chelates.
**Standardization**
The 1% elemental vanadium standardization by weight is the only commercial benchmark; third-party verification of elemental vanadium content is advisable given variability in chelation efficiency.
**Not Water-Soluble**
The chelate is described as immiscible in water, limiting liquid formulation options and requiring encapsulation or tablet compression for oral delivery.
Nutritional Profile
Vanadium Nicotinate Glycinate Chelate is not a food or nutritional ingredient in the classical sense and contributes no meaningful macronutrients, dietary fiber, or primary vitamins to the diet. At the 1% elemental vanadium standardization, a 1 mg dose of chelate delivers approximately 10 mcg elemental vanadium alongside trace quantities of nicotinate (niacin derivative) and glycine — neither of which is present in pharmacologically relevant amounts at typical supplement serving sizes. Dietary vanadium intake from food sources (mushrooms, shellfish, parsley, black pepper, whole grains) is estimated at 10–60 mcg/day in Western diets, and vanadium has not been established as an essential nutrient with a Recommended Dietary Allowance. Bioavailability of the chelated form is modestly enhanced compared to inorganic vanadyl sulfate, with the chelation matrix extending blood half-life from ~5 minutes to 7–30 minutes in rodent pharmacokinetic studies, though human bioavailability data for this specific form are unpublished.
How It Works
Mechanism of Action
Vanadium ions, particularly in the +4 (vanadyl) and +5 (vanadate) oxidation states, act as insulin mimetics primarily by inhibiting protein tyrosine phosphatases (PTPs) — enzymes that dephosphorylate and deactivate the insulin receptor — thereby prolonging tyrosine kinase activity of the insulin receptor and amplifying downstream PI3K-Akt signaling, which drives GLUT4 vesicle translocation to plasma membranes and increases intracellular glucose flux. Vanadium also inhibits Na⁺/K⁺-ATPase, contributing to enhanced glucose transport, and suppresses gluconeogenic gene expression via FoxO1 transcription factor regulation, reducing hepatic glucose output. At the molecular level, vanadium may form oligovanadate species that interact directly with protein cysteine residues or DNA, and free radical-mediated oxidative modifications of phosphatase active sites contribute to its inhibitory effects on PTP activity. The nicotinate-glycinate chelation is hypothesized to protect vanadium from premature oxidation or precipitation in the gastrointestinal tract, facilitating more intact absorption and delivery to target tissues.
Clinical Evidence
Clinical investigation of vanadium compounds for glycemic control has primarily involved vanadyl sulfate and organic chelates like BMOV in small pilot trials enrolling 8–16 participants with type 2 diabetes or impaired glucose tolerance, with outcomes including fasting plasma glucose, hepatic glucose production measured by isotope dilution, and insulin sensitivity via euglycemic clamp. These studies reported statistically significant but modest reductions in fasting glucose and hepatic glucose output, alongside elevated serum vanadium levels of 1–10 μM, confirming absorption and target engagement. No clinical trials have been published specifically for Vanadium Nicotinate Glycinate Chelate, and long-term safety data (beyond 6 weeks) remain absent for any vanadium supplement form in humans. Confidence in efficacy claims for this chelate form is low, and regulatory bodies have not approved vanadium supplements for any medical indication.
Safety & Interactions
At supplemental doses providing trace elemental vanadium (under 100 mcg/day), Vanadium Nicotinate Glycinate Chelate is generally considered low-risk in healthy adults, but higher pharmacological doses (>1 mg elemental vanadium/day) carry documented risks including gastrointestinal distress, green discoloration of the tongue, and potential nephrotoxicity from tissue accumulation; vanadium in the +5 oxidation state exhibits genotoxicity including chromosomal aberrations and DNA strand breaks in vitro. Vanadium supplements can theoretically potentiate the effects of insulin, sulfonylureas, metformin, and other antidiabetic drugs, increasing hypoglycemia risk, and patients on glucose-lowering medications should use this ingredient only under medical supervision. Chronic use raises concerns about cumulative tissue deposition, particularly in bone and kidney, as vanadium is not efficiently cleared and long-term safety in humans has not been established beyond 6-week pilot studies. Use during pregnancy and lactation is contraindicated due to embryotoxicity observed in animal studies and the complete absence of human safety data in these populations; no established tolerable upper intake level (UL) exists for supplemental vanadium.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Vanadium Nicotinate Glycinate ChelateChelated VanadiumVanadyl Nicotinate GlycinateVanadium Amino Acid Chelate1% Vanadium Chelate
Frequently Asked Questions
What is Vanadium Nicotinate Glycinate used for?
Vanadium Nicotinate Glycinate Chelate is primarily used as a trace mineral supplement to support blood glucose regulation and insulin sensitivity. It works by inhibiting protein tyrosine phosphatases (PTPs), which prolongs insulin receptor activation and enhances GLUT4-mediated glucose uptake — mechanisms demonstrated in preclinical studies and small human trials using related vanadium compounds, though no clinical trials specific to this chelate form have been published.
How much elemental vanadium is in Vanadium Nicotinate Glycinate Chelate?
Commercial Vanadium Nicotinate Glycinate Chelate powder, such as that produced by Albion Laboratories and Balchem, is standardized to 1% elemental vanadium by weight, meaning 100 mg of chelate provides 1 mg (1,000 mcg) of elemental vanadium. Most finished supplement products dose far below this level, typically delivering 25–100 mcg elemental vanadium per serving to remain within a conservative trace mineral range.
Is Vanadium Nicotinate Glycinate safe to take daily?
At trace supplemental doses under 100 mcg elemental vanadium per day, Vanadium Nicotinate Glycinate Chelate is considered relatively low risk for healthy adults, but long-term safety data in humans are absent beyond 6-week studies. At higher pharmacological doses, vanadium can accumulate in bone and kidney tissue, cause gastrointestinal side effects, and exhibit genotoxicity; pregnancy, lactation, and concurrent use with antidiabetic medications are specific contraindications due to embryotoxic potential and hypoglycemia risk.
How does chelated vanadium differ from vanadyl sulfate?
Vanadyl sulfate is an inorganic vanadium salt with a blood half-life of approximately 5 minutes and lower gastrointestinal tolerability, while Vanadium Nicotinate Glycinate Chelate complexes vanadium with nicotinic acid and glycine to extend its blood half-life to 7–30 minutes in rodent studies and reduce gastrointestinal irritation. The chelation matrix is hypothesized to protect the vanadium ion from premature oxidation and precipitation during intestinal absorption, potentially increasing organ-level delivery, though direct head-to-head human pharmacokinetic comparisons have not been published.
Can Vanadium Nicotinate Glycinate replace diabetes medication?
No — Vanadium Nicotinate Glycinate Chelate is a dietary supplement and has not been approved by any regulatory authority to treat, cure, or replace medication for diabetes or any other medical condition. While vanadium compounds have demonstrated insulin-mimetic properties in small pilot studies with type 2 diabetic patients, the evidence is insufficient to support use as a diabetes therapy, and combining vanadium supplements with insulin or oral antidiabetics without medical supervision poses a significant hypoglycemia risk.
Does Vanadium Nicotinate Glycinate Chelate need to be taken with food?
Taking Vanadium Nicotinate Glycinine Chelate with food may enhance absorption and reduce potential gastrointestinal irritation, though research on optimal timing is limited. The chelated form is generally well-tolerated on an empty stomach, but individual tolerance varies. Consistency with meal timing helps establish a reliable supplementation routine and may improve compliance.
Who should avoid taking Vanadium Nicotinate Glycinate Chelate?
People with kidney disease or those taking medications that affect renal function should consult a healthcare provider before supplementing with vanadium, as the mineral is excreted primarily through the kidneys. Pregnant and breastfeeding women should avoid vanadium supplementation due to insufficient safety data. Those with insulin-dependent diabetes should use vanadium only under medical supervision, as it may potentiate insulin effects and increase hypoglycemia risk.
What clinical evidence supports the use of Vanadium Nicotinate Glycinate Chelate for blood sugar control?
Human clinical trials demonstrate that vanadium supplementation can modestly improve fasting blood glucose and insulin sensitivity in individuals with impaired glucose tolerance and type 2 diabetes, with typical response times of 4–12 weeks. The nicotinate glycinate chelate form is designed to improve bioavailability compared to inorganic vanadium salts, though direct comparative clinical trials in humans are limited. Most evidence comes from smaller studies (n=20–60), suggesting that larger, well-controlled trials are needed to establish optimal dosing and long-term efficacy.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w vanadium-nicotinate-glycinate-chelate curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
